Hypertension in Black Patients: An Update

References

• . Chobanian AV, Bakris GL, Black HR, ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206–1252
   PubMed Web of Science ®Google Scholar
• . Flack JM, Sica DA, Bakris G, ; International Society on Hypertension in Blacks. Management of high blood pressure in blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension. 2010;56(5):780–800
   PubMed Web of Science ®Google Scholar
• . Flack JM, Nasser SA, Levy PD. Therapy of hypertension in African Americans. Am J Cardiovasc Drugs. 2011;11(2):83–92
   PubMed Web of Science ®Google Scholar
• . Wong MD, Shapiro MF, Boscardin WJ, Ettner SL. Contribution of major diseases to disparities in mortality. N Engl J Med. 2002;347(20):1585–1592
   PubMed Web of Science ®Google Scholar
• . Odedosu T, Schoenthaler A, Vieira DL, Agyemang C, Ogedegbe G. Overcoming barriers to hypertension control in African Americans. Cleve Clin J Med. 2012;79(1):46–56
   PubMed Web of Science ®Google Scholar
• . Snipes SA, Sellers SL, Tafawa AO, Cooper LA, Fields JC, Bonham VL. Is race medically relevant? A qualitative study of physicians' attitudes about the role of race in treatment decision-making. BMC Health Serv Res. 2011;11:183
   PubMed Web of Science ®Google Scholar
• . Wright JT Jr, Bakris G, Greene T, ; African American Study of Kidney Disease and Hypertension Study Group. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA. 2002;288(19):2421–2431
   PubMed Web of Science ®Google Scholar
• . Brenner BM, Cooper ME, de Zeeuw D, ; RENAAL Study Investigators. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345(12):861–869
   PubMed Web of Science ®Google Scholar
• . de Zeeuw D, Ramjit D, Zhang Z, . Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAAL. Kidney Int. 2006;69(9):1675–1682
   PubMed Web of Science ®Google Scholar
• . ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981–2997
   PubMed Web of Science ®Google Scholar
• . Wright JT Jr, Dunn JK, Cutler JA, ; ALLHAT Collaborative Research Group. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA. 2005;293(13):1595–1608
   PubMed Web of Science ®Google Scholar
• . Cushman WC, Davis BR, Pressel SL, ; ALLHAT Collaborative Research Group. Mortality and morbidity during and after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. J Clin Hypertens (Greenwich). 2012;14(1):20–31
   PubMed Web of Science ®Google Scholar
• . Weir MR, Bakris GL, Weber MA, . Renal outcomes in hypertensive black patients at high cardiovascular risk. Kidney Int. 2012;81(6):568–576
   PubMed Web of Science ®Google Scholar
• . Odili AN, Richart T, Thijs L, ; NOAAH Investigators. Rationale and design of the Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) trial. Blood Press. 2011;20(5):256–266
   PubMed Web of Science ®Google Scholar
• . Odili AN, Ezeala-Adikaibe B, Ndiaye MB, . Progress report on the first sub-Saharan Africa trial of newer versus older antihypertensive drugs in native black patients. Trials. 2012;13(1):59
   PubMedGoogle Scholar
• . Romanelli RJ, Schiro TA, Jukes T, , Wong KS, Ishisaka DY. Disparities in blood pressure control within a community-based provider network: an exploratory analysis. Ann Pharmacother. 2011;45(12):1473–1482
   PubMed Web of Science ®Google Scholar
• . Axon RN, Gebregziabher M, Echols C, Msph GG, Egede LE. Racial and ethnic differences in longitudinal blood pressure control in veterans with type 2 diabetes mellitus. J Gen Intern Med. 2011;26(11):1278–1283
   PubMed Web of Science ®Google Scholar
• . Choma NN, Griffin MR, Kaltenbach LA Greevy RA Roumie CL. Blood pressure control among patients with hypertension and newly diagnosed diabetes. Diabet Med. 2012;29(9):1126–1133
   PubMed Web of Science ®Google Scholar
• . Selassie A, Wagner CS, Laken ML, Ferguson ML, Ferdinand KC, Egan BM. Progression is accelerated from prehypertension to hypertension in blacks. Hypertension. 2011;58(4):579–587
   PubMed Web of Science ®Google Scholar
• . Glasser SP, Judd S, Basile J, . Prehypertension, racial prevalence and its association with risk factors: analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Am J Hypertens. 2011;24(2):194–199
   PubMed Web of Science ®Google Scholar
• . Covelli MM, Wood CE, Yarandi HN. Biologic measures as epidemiological indicators of risk for the development of hypertension in an African American adolescent population. J Cardiovasc Nurs. 2012;27(6):476–484
   PubMed Web of Science ®Google Scholar
• . Pimenta E, Oparil S. Prehypertension: epidemiology, consequences and treatment. Nat Rev Nephrol. 2010;6(1):21–30
   PubMed Web of Science ®Google Scholar
• . Gupta P, Nagaraju SP, Gupta A, Mandya Chikkalingaiah KB. Prehypertension—time to act. Saudi J Kidney Dis Transpl. 2012;23(2):223–233
   PubMedGoogle Scholar
• . Veerabhadrappa P, Diaz KM, Feairheller DL, . Endothelial-dependent flow-mediated dilation in African Americans with masked-hypertension. Am J Hypertens. 2011;24(10):1102–1107
   PubMed Web of Science ®Google Scholar
• . Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol. 2010;7(5):245–257
   PubMed Web of Science ®Google Scholar
• . Colt JS, Schwartz K, Graubard BI, ; Hypertension and risk of renal cell carcinoma among white and black Americans. Epidemiology. 2011;22(6):797–804
   PubMed Web of Science ®Google Scholar
• . Sakata K, Suwazono Y, Harada H, Okubo Y, Kobayashi E, Nogawa K. The relationship between shift work and the onset of hypertension in male Japanese workers. J Occup Environ Med. 2003;45(9):1002–1006
   PubMed Web of Science ®Google Scholar
• . Hublin C, Partinen M, Koskenvuo K, Silventoinen K, Koskenvuo M, Kaprio J. Shift-work and cardiovascular disease: a population-based 22-year follow-up study. Eur J Epidemiol. 2010;25(5):315–323
   PubMed Web of Science ®Google Scholar
• . Lieu SJ, Curhan GC, Schernhammer ES, Forman J. Rotating night shift work and disparate hypertension risk in African-Americans. J Hypertens. 2012;30(1):61–66
   PubMed Web of Science ®Google Scholar
• . Fischer MJ, Kimmel PL, Greene T, ; AASK Study Group. Elevated depressive affect is associated with adverse cardiovascular outcomes among African Americans with chronic kidney disease. Kidney Int. 2011;80(6):670–678
   PubMed Web of Science ®Google Scholar
• . Grigoryan L, Pavlik VN, Hyman DJ. Predictors of antihypertensive medication adherence in two urban health-care systems. Am J Hypertens. 2012;25(7):735–738
   PubMed Web of Science ®Google Scholar
• . Ishisaka DY, Jukes T, Romanelli RJ, Wong KS, Schiro TA. Disparities in adherence to and persistence with antihypertensive regimens: an exploratory analysis from a community-based provider network. J Am Soc Hypertens. 2012;6(3):201–209
   PubMed Web of Science ®Google Scholar
• . Fernandez S, Tobin JN, Cassells A, Diaz-Gloster M, Kalida C, Ogedegbe G. The counseling African Americans to Control Hypertension (CAATCH) Trial: baseline demographic, clinical, psychosocial, and behavioral characteristics. Implement Sci. 2011;6:100
   PubMed Web of Science ®Google Scholar
• . Lewis LM, Schoenthaler AM, Ogedegbe G. Patient factors, but not provider and health care system factors, predict medication adherence in hypertensive black men. J Clin Hypertens (Greenwich). 2012;14(4):250–255
   PubMed Web of Science ®Google Scholar
• . Warren-Findlow J, Seymour RB, Brunner Huber LR. The association between self-efficacy and hypertension self-care activities among African American adults. J Community Health. 2012;37(1):15–24
   PubMed Web of Science ®Google Scholar
• . Hebert PL, Sisk JE, Tuzzio L, . Nurse-led disease management for hypertension control in a diverse urban community: a randomized trial. J Gen Intern Med. 2012;27(6):630–639
   PubMed Web of Science ®Google Scholar
• . Migneault JP, Dedier JJ, Wright JA, . A culturally adapted telecommunication system to improve physical activity, diet quality, and medication adherence among hypertensive African-Americans: a randomized controlled trial. Ann Behav Med. 2012;43(1):62–73
   PubMed Web of Science ®Google Scholar
• . Jackson GL, Oddone EZ, Olsen MK, . Racial differences in the effect of a telephone-delivered hypertension disease management program. J Gen Intern Med. 2012;27(12):1682–1689
   PubMed Web of Science ®Google Scholar
• . Ogedegbe GO, Boutin-Foster C, Wells MT, . A randomized controlled trial of positive-affect intervention and medication adherence in hypertensive African Americans. Arch Intern Med. 2012;172(4):322–326
   PubMed Web of Science ®Google Scholar
• . Johnson W, Shaya FT, Khanna N, . The Baltimore Partnership to Educate and Achieve Control of Hypertension (The BPTEACH Trial): a randomized trial of the effect of education on improving blood pressure control in a largely African American population. J Clin Hypertens (Greenwich). 2011;13(8):563–570
   PubMed Web of Science ®Google Scholar
• . Turner BJ, Hollenbeak CS, Liang Y, Pandit K, Joseph S, Weiner MG. A randomized trial of peer coach and office staff support to reduce coronary heart disease risk in African-Americans with uncontrolled hypertension. J Gen Intern Med. 2012;27(10):1258–1264
   PubMed Web of Science ®Google Scholar
• . Schoenthaler A, Luerassi L, Teresi JA, . A practice-based trial of blood pressure control in African Americans (TLC-Clinic): study protocol for a randomized controlled trial. Trials. 2011;12:265
   PubMedGoogle Scholar
• . Abdellatif AA. Role of single-pill combination therapy in optimizing blood pressure control in high-risk hypertension patients and management of treatment-related adverse events. J Clin Hypertens (Greenwich). 2012;14(10):718–726
   PubMed Web of Science ®Google Scholar
• . Egan BM, Bandyopadhyay D, Shaftman SR, Wagner CS, Zhao Y, Yu-Isenberg KS. Initial monotherapy and combination therapy and hypertension control the first year. Hypertension. 2012;59(6):1124–1131
   PubMed Web of Science ®Google Scholar
• . Douglas JG, Bakris GL, Epstein M, ; Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Management of high blood pressure in African Americans: a consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med. 2003;163(5):525–541
   PubMedGoogle Scholar
• . Kaplan NM. Primary hypertension: natural history and evaluation. In: Kaplan's Clinical Hypertension. 8th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2002:157–159
   Google Scholar